Rosario Cuomo

Rosario Cuomo

Auto-generated profile, based on publicly available information

Rosario Cuomo

Department of Clinical Medicine and Surgery, Federico II University of Naples, Naples, Italy

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
FGFrancesca Guida
Francesca Guida
FTF. Turco
F. Turco
MIM. Iannotta
M. Iannotta
DGDanilo De Gregorio
Danilo De Gregorio
IPI. Palumbo
I. Palumbo
SMS. Maione
S. Maione

30 September 2013 in Gut
Verified
Journal Article
Closed access
PDF file
GEGiuseppe Esposito
Giuseppe Esposito
ECElena Capoccia
Elena Capoccia
FTFabio Turco
Fabio Turco
IPIlaria Palumbo
Ilaria Palumbo
JLJIE LU
JIE LU
Luca Steardo Jr.Luca Steardo Jr.
Luca Steardo Jr.
Objective Enteric glia activation has been reported to amplify intestinal inflammation via the enteroglial-specific S100B protein. This neurotrophin promotes macrophage recruitment in the mucosa, amplify colonic inflammation and interacts with toll-like receptors (TLR). Molecules inhibiting S100B-driven enteric activation might mitigate the course of ulcerative colitis (UC). This study aims to investigate the effects of palmitoylethanolammide (PEA), a drug able to counteract astroglial activation in the central nervous system, on intestinal inflammation, in humans and mice. Design Mouse models of dextran sodium sulphate (DSS)-induced colitis, colonic biopsies deriving from UC patients and primary cultures of mouse and human enteric glial cells (EGC), have been used to assess the effects of PEA, alone or in the presence of specific PPARα or PPARγ antagonists, on: macroscopic signs of UC (DAI score, colon length, spleen weight, macrophages/neutrophils infiltration); the expression and release of proinflammatory markers typical of UC; TLR pathway in EGCs. Results PEA treatment improves all macroscopic signs of UC and decreases the expression and release of all the proinflammatory markers tested. PEA anti-inflammatory effects are mediated by the selective targeting of the S100B/TLR4 axis on ECG, causing a downstream inhibition of nuclear factor kappa B (NF-kB)-dependent inflammation. Antagonists at PPARα, but not PPARγ, abolished PEA effects, in mice and in humans. Conclusions Because of its lack of toxicity, its ability in reducing inflammation and its selective PPARα action, PEA might be an innovative molecule to broaden pharmacological strategies against UC.

11 August 2003 in Gut
Verified
Journal Article
Open access
PDF file
JTJ Tack
J Tack
PCP Caenepeel
P Caenepeel
HPHubert Piessevaux
Hubert Piessevaux
RCR Cuomo
R Cuomo
JJJ Janssens
J Janssens
Aims: Impaired gastric accommodation is a major pathophysiological mechanism in functional dyspepsia. The aim of the present work was to assess a satiety drinking test in the evaluation of accommodation in health and dyspepsia. Methods: Twenty five controls and 37 severely dyspeptic patients seen at a tertiary care centre completed a dyspepsia questionnaire, and gastric emptying and gastric barostat studies. The amount of liquid meal ingested at maximum satiety during a slow satiety drinking test was determined. In controls, we studied the influence of caloric density and of pharmacological agents that influence accommodation. Results: In patients, satiety scores were higher and maximum satiety occurred at lower calories (542 (50) v 1508 (53) kcal; p<0.0001). Six patients had required nutritional support, but excluding these did not alter the correlations. With increasing severity of early satiety, less calories were ingested at maximum satiety. In multivariate analysis, the amount of calories was significantly correlated to accommodation but not to gastric emptying or sensitivity. Sensitivity and specificity of the satiety test in predicting impaired accommodation reached 92% and 86%, respectively. At different caloric densities, ingested volume rather than caloric load determined maximum satiety. Pharmacological agents (sumatriptan, cisapride, erythromycin) affected the satiety test according to their effect on accommodation. Conclusion: A slow caloric drinking test can be used to evaluate accommodation and early satiety. It provides a non-invasive method of predicting impaired accommodation and quantifying pharmacological influences on accommodation.

3 January 2013 in Gut
Verified
Journal Article
Closed access
PDF file
FTFabio Turco
Fabio Turco
GSGiovanni Sarnelli
Giovanni Sarnelli
CCCarla Cirillo
Carla Cirillo
IPIlaria Palumbo
Ilaria Palumbo
FGFrancesco De Giorgi
Francesco De Giorgi
RCRosario Cuomo
Rosario Cuomo
Objective: Enteric glial cells (EGC) have been suggested to participate in host–bacteria cross-talk, playing a protective role within the gut. The way EGC interact with microorganisms is still poorly understood. We aimed to evaluate whether: EGC participate in host–bacteria interaction; S100B and Toll-like receptor (TLR) signalling converge in a common pathway leading to nitric oxide (NO) production. Design: Primary cultures of human EGC were exposed to pathogenic (enteroinvasive Escherichia coli ; EIEC) and probiotic ( Lactobacillus paracasei F19) bacteria. Cell activation was assessed by evaluating the expression of cFos and major histocompatibility complex (MHC) class II molecules. TLR expression in EGC was evaluated at both baseline and after exposure to bacteria by real-time PCR, fluorescence microscopy and western blot analysis. S100B expression and NO release from EGC, following exposure to bacteria, were measured in the presence or absence of specific TLR and S100B pathway inhibitors. Results: EIEC activated EGC by inducing the expression of cFos and MHC II. EGC expressed TLR at baseline. Pathogens and probiotics differentially modulated TLR expression in EGC. Pathogens, but not probiotics, significantly induced S100B protein overexpression and NO release from EGC. Pretreatment with specific inhibitors of TLR and S100B pathways abolished bacterial-induced NO release from EGC. Conclusions: Human EGC interact with bacteria and discriminate between pathogens and probiotics via a different TLR expression and NO production. In EGC, NO release is impaired in the presence of specific inhibitors of the TLR and S100B pathways, suggesting the presence of a novel common pathway involving both TLR stimulation and S100B protein upregulation.

21 November 2016 in Gut
Verified
Journal Article
Open access
PDF file
MHMaria Henström
Maria Henström
LDLena Diekmann
Lena Diekmann
FBFerdinando Bonfiglio
Ferdinando Bonfiglio
FHFatemeh Hadizadeh
Fatemeh Hadizadeh
EKEva-Maria Kuech
Eva-Maria Kuech
MDMauro D'Amato
Mauro D'Amato
Objective: IBS is a common gut disorder of uncertain pathogenesis. Among other factors, genetics and certain foods are proposed to contribute. Congenital sucrase–isomaltase deficiency (CSID) is a rare genetic form of disaccharide malabsorption characterised by diarrhoea, abdominal pain and bloating, which are features common to IBS. We tested sucrase–isomaltase ( SI ) gene variants for their potential relevance in IBS. Design: We sequenced SI exons in seven familial cases, and screened four CSID mutations (p.Val557Gly, p.Gly1073Asp, p.Arg1124Ter and p.Phe1745Cys) and a common SI coding polymorphism (p.Val15Phe) in a multicentre cohort of 1887 cases and controls. We studied the effect of the 15Val to 15Phe substitution on SI function in vitro. We analysed p.Val15Phe genotype in relation to IBS status, stool frequency and faecal microbiota composition in 250 individuals from the general population. Results: CSID mutations were more common in patients than asymptomatic controls (p=0.074; OR=1.84) and Exome Aggregation Consortium reference sequenced individuals (p=0.020; OR=1.57). 15Phe was detected in 6/7 sequenced familial cases, and increased IBS risk in case–control and population-based cohorts, with best evidence for diarrhoea phenotypes (combined p=0.00012; OR=1.36). In the population-based sample, 15Phe allele dosage correlated with stool frequency (p=0.026) and Parabacteroides faecal microbiota abundance (p=0.0024). The SI protein with 15Phe exhibited 35% reduced enzymatic activity in vitro compared with 15Val (p<0.05). Conclusions: SI gene variants coding for disaccharidases with defective or reduced enzymatic activity predispose to IBS. This may help the identification of individuals at risk, and contribute to personalising treatment options in a subset of patients.

1 February 2016 in Inflammatory Bowel Diseases
Verified
Journal Article
Open access
PDF file
FOFernando Ochoa-Cortes
Fernando Ochoa-Cortes
FTFabio Turco
Fabio Turco
ALAndromeda Linan-Rico
Andromeda Linan-Rico
SSSuren Soghomonyan
Suren Soghomonyan
EWEmmett Whitaker
Emmett Whitaker
FCFievos L. Christofi
Fievos L. Christofi
The word “glia” is derived from the Greek word “γλoια,” glue of the enteric nervous system, and for many years, enteric glial cells (EGCs) were belie